OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The realization that there is a very close relationship between tumours and blood vessels goes back to the very first description of this group of diseases. The term angiogenesis was first used in 1787 to describe new blood vessels emerging from an existing vasculature and in 1971 the hypothesis that tumour growth is always dependent on angiogenesis was proposed. Eventually in 2000, ‘sustained angiogenesis’ was included as one of the six original hallmarks of cancer but, this turned out not to be true as in 1996 clinically detectable, grown up non-angiogenic primary and metastatic tumours were formally described by our laboratory. The ability of these tumours to exploit and co-opt pre-existing vessels has been confirmed in a variety of organs and a new field in cancer biology has opened. This seminar will summarise what we know about the biology of these tumours and of the vessel co-option process.
